SARCOMA,SOFT TISSUE
Clinical trials for SARCOMA,SOFT TISSUE explained in plain language.
Never miss a new study
Get alerted when new SARCOMA,SOFT TISSUE trials appear
Sign up with your email to follow new studies for SARCOMA,SOFT TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy shows promise against rare sarcomas
Disease control OngoingThis study tests a combination of two immunotherapy drugs (pembrolizumab and eftilagimod alpha) plus radiation before surgery for adults with soft tissue sarcoma. The goal is to see if this approach shrinks tumors more effectively. About 40 participants with high-risk, non-spread…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated May 26, 2026 06:14 UTC
-
New hope for rare sarcomas: targeted drug niraparib under study
Disease control OngoingThis study tests whether the drug niraparib can help control advanced soft tissue sarcoma that has specific DNA repair mutations. Eight adults with tumors that cannot be removed by surgery or have spread will receive niraparib. Researchers will track how long the cancer stays und…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New drug combo shows promise in early sarcoma trial
Disease control OngoingThis early-phase study tests a new drug (ADI-PEG 20) combined with chemotherapy and radiation before surgery for soft tissue sarcoma. The goal is to find the safest dose and see if it helps shrink tumors. Only 6 people are enrolled so far, and the study is actively monitoring for…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 06:03 UTC
-
Virus injection and radiation aim to shrink sarcomas before surgery
Disease control OngoingThis study tests a new approach for people with advanced soft tissue sarcoma that cannot be easily removed with surgery alone. Participants receive a virus-based injection directly into the tumor along with radiation therapy before surgery. The goal is to see if this combination …
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated May 26, 2026 06:03 UTC
-
Immunotherapy and radiation combo shows promise against rare sarcomas
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard radiation therapy can shrink soft tissue sarcomas more effectively before surgery. About 62 adults with operable sarcoma will receive different sequences of radiation, atezolizumab, and surgery. The g…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New combo therapy shows promise for Hard-to-Treat sarcomas
Disease control OngoingThis early-phase study tested whether combining the immunotherapy drug pembrolizumab with precise, high-dose radiation (SBRT) is feasible for people with advanced soft-tissue sarcoma that has spread or cannot be removed by surgery. Nine participants were enrolled to see if they c…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New drug duo targets hard-to-treat sarcoma
Disease control OngoingThis study tests whether combining two drugs (etrumadenant and zimberelimab) can shrink tumors or slow the disease in people with advanced dedifferentiated liposarcoma that has returned, spread, or cannot be removed by surgery. About 16 adults with this rare soft-tissue cancer wi…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New combo therapy aims to turn tumors against themselves in advanced cancer patients
Disease control OngoingThis early-phase study tests whether a mix of drugs and targeted radiation can help the immune system recognize and attack hard-to-treat solid tumors. About 14 adults with advanced melanoma, breast cancer, or other solid cancers that cannot be surgically removed will receive inje…
Matched conditions: SARCOMA,SOFT TISSUE
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:38 UTC